Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

[1]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[2]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[3]  J. Bradbury.  HIV-1-resistant individuals may lack HIV-1 coreceptor , 1996, The Lancet.

[4]  B. Sha,et al.  Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. , 1996, Journal of immunology.

[5]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[6]  M. Dierich,et al.  Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55) , 1996, The Journal of experimental medicine.

[7]  R. Donn,et al.  Mannose-binding protein genotypes and recurrent infection , 1995, The Lancet.

[8]  A. Svejgaard,et al.  Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency , 1995, The Lancet.

[9]  S. Thiel,et al.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. , 1995, Journal of immunology.

[10]  D. Vergani,et al.  Circulating levels of mannose binding protein in human immunodeficiency virus infection. , 1995, The Journal of infection.

[11]  M. Turner,et al.  Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. , 1995, Immunology.

[12]  S. Thiel,et al.  The level of the serum opsonin, mannan‐binding protein in HIV‐1 antibody‐positive patients , 1995, Clinical and experimental immunology.

[13]  M. Turner,et al.  Mannose binding protein gene mutations associated with unusual and severe infections in adults , 1995, The Lancet.

[14]  D. Gordon,et al.  Regulation of C3 deposition on gp120 coated CD4 positive cells by decay accelerating factor and factor H , 1994, Immunology and cell biology.

[15]  S. Thiel,et al.  Binding of mannan‐binding protein to various bacterial pathogens of meningitis , 1994, Clinical and experimental immunology.

[16]  S. Thiel,et al.  Complement activation upon binding of mannan‐binding protein to HIV envelope glycoproteins , 1993, AIDS.

[17]  R. Ezekowitz,et al.  Collectins: pattern recognition molecules involved in first line host defense. , 1993, Current opinion in immunology.

[18]  S. Thiel,et al.  Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations , 1992, Clinical and experimental immunology.

[19]  S. Thiel,et al.  DIALLELIC POLYMORPHISM MAY EXPLAIN VARIATIONS OF THE BLOOD CONCENTRATION OF MANNAN‐BINDING PROTEIN IN ESKIMOS, BUT NOT IN BLACK AFRICANS , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[20]  T. Fujita,et al.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease , 1992, The Journal of experimental medicine.

[21]  A. Hill,et al.  High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene , 1992 .

[22]  F. Hentges,et al.  Prolonged clinically asymptomatic evolution after HIV‐1 infection is marked by the absence of complement C4 null alleles at the MHC , 1992, Clinical and experimental immunology.

[23]  R. Levinsky,et al.  Molecular basis of opsonic defect in immunodeficient children , 1991, The Lancet.

[24]  S. Mallal,et al.  Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. , 1990, Human immunology.

[25]  J. Phair,et al.  A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection A report from the Multicenter AIDS Cohort Study , 1990, The Lancet.

[26]  D. Montefiori,et al.  Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. , 1990, Virology.

[27]  S. Thiel,et al.  Oligosaccharide‐mediated interactions of the envelope glycoprotein gp120 of HIV‐1 that are independent of CD4 recognition , 1989, AIDS.

[28]  S. Thiel,et al.  ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION , 1989, The Lancet.

[29]  M. Taylor,et al.  Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. , 1989, The Biochemical journal.

[30]  K. Drickamer,et al.  Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man. , 1989, The Biochemical journal.

[31]  J. Groopman,et al.  A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus , 1989, The Journal of experimental medicine.

[32]  P. Cameron,et al.  Influence of C4 null genes on infection with human immunodeficiency virus , 1988, British medical journal.

[33]  P. Simmonds,et al.  HLA HAPLOTYPE A1 B8 DR3 AS A RISK FACTOR FOR HIV-RELATED DISEASE , 1988, The Lancet.

[34]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[35]  L. Montagnier,et al.  AIDS research at EC level. , 1995 .